APVO
Aptevo Therapeutics Inc.
Key Financials
Net Income
$-25967000
↓ 7.6%
Revenue
$3.1M
0.0%
Operating Income
$-26312000
↓ 7.0%
Total Liabilities
$9.8M
↓ 9.4%
EPS (Diluted)
$-87.27
↑ 0.1%
Cash & Equivalents
$21.6M
↑ 148.1%
Shareholders' Equity
$17.4M
↑ 265.5%
Total Assets
$27.2M
↑ 74.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| S-8 | 9/25/2026 | View on SEC |
| 8-K | 9/24/2026 | View on SEC |
| 8-K | 9/23/2026 | View on SEC |
| 424B4 | 9/3/2026 | View on SEC |
| 8-K | 9/3/2026 | View on SEC |
| EFFECT | 9/2/2026 | View on SEC |
| DEF 14A | 8/31/2026 | View on SEC |
| D | 8/26/2026 | View on SEC |
| PRE 14A | 8/21/2026 | View on SEC |
| S-1 | 8/21/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | APVO |
| Company Name | Aptevo Therapeutics Inc. |
| CIK | 1671584 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 206-838-0500 |